GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » ROE % Adjusted to Book Value

Alfresa Holdings (Alfresa Holdings) ROE % Adjusted to Book Value : 10.09% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Alfresa Holdings ROE % Adjusted to Book Value?

Alfresa Holdings's ROE % for the quarter that ended in Dec. 2023 was 7.87%. Alfresa Holdings's PB Ratio for the quarter that ended in Dec. 2023 was 0.78. Alfresa Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 10.09%.


Alfresa Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Alfresa Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings ROE % Adjusted to Book Value Chart

Alfresa Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.98 4.60 5.38 6.84 7.38

Alfresa Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.28 4.17 8.06 10.09 9.26

Competitive Comparison of Alfresa Holdings's ROE % Adjusted to Book Value

For the Medical Distribution subindustry, Alfresa Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alfresa Holdings's ROE % Adjusted to Book Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's ROE % Adjusted to Book Value falls into.



Alfresa Holdings ROE % Adjusted to Book Value Calculation

Alfresa Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.76% / 0.78
=7.38%

Alfresa Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.87% / 0.78
=10.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alfresa Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alfresa Holdings (Alfresa Holdings) Business Description

Traded in Other Exchanges
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines